UBARACHNOID hemorrhage after aneurysm rupture often leads to cerebral vasospasm. Despite standard medical treatment with calcium channel blockers and hypertensive, hypervolemic, hemodilution therapy, up to one third of patients with vasospasm develop an ischemic neurological deficit. 13, 15, 17, 22 When maximum medical therapy for vasospasm fails, early and aggressive endovascular intervention with balloon angioplasty can improve clinical outcome. 1, 2, 7, 14, 20, 26 However, one disadvantage of balloon angioplasty is its limited ability to enter sharply angled vessels.
Endovascular Technique
The technique of performing balloon angioplasty by using the standard 4-mm low-pressure nondetachable silicone balloon microcatheter (model ITC NDSB/8502 with 0.2-ml maximum volume, 0.85-mm diameter/4.1-mm length deflated, 4.2-mm diameter/11-mm length inflated [standard ITC balloon]; Target Therapeutics/Boston Scientific, Watertown, MA) for symptomatic vasospasm has been previously described. 10, 23 If the initial diagnostic cerebral angiogram reveals normal caliber prevasospastic A 1 segments, instead of using the standard ITC balloon, a low-profile high-pressure balloon microcatheter (Stealth Balloon Dilation System model 120502; inflated 2.5-mm diameter, 10-mm length; Target Therapeutic/Boston Scientific) is advanced across the narrowed A 1 (Fig. 1) .
With the assistance of biplane digital fluoroscopy and roadmapping, attempts are initially made to cross the narrowed A 1 segment with the Terumo gold tip. If successful, the microguidewire is carefully advanced to the distal pericallosal or callosomarginal artery (Fig. 2) . Once the microcatheter is positioned across the A 1 segment with the aid of real-time fluoroscopic monitoring, the Stealth balloon microcatheter is dilated several times. The balloon is inflated with contrast agent that is injected using a LuerLoc syringe attached to the Stealth balloon microcatheter via a rotating hemostatic valve.
If attempts to cross A 1 -segment vasospasm with the Terumo gold tip are unsuccessful, the Transend EX can be advanced through the Stealth balloon microcatheter after shaping a tight 3-to 4-mm curve at its tip. This aids navigation of the acute bend of the terminal internal carotid artery (ICA) and the A 1 junction. Once the A 1 segment is crossed, the Transend EX is exchanged for the stiffer Terumo gold tip, which is carefully advanced to position its tip in the distal ACA. If the initial tight curve is not helpful in navigating across the A 1 segment, other curves can be shaped at the tip of the Transend EX and the process can be repeated.
We have used this technique with good results in treating 10 A 1 segments narrowed by vasospasm in seven patients (Table 1) .
Discussion
For patients who survive the initial event of aneurysmal rupture, after the aneurysm has been excluded by surgical clipping or endovascular coil placement, vasospasm remains the most important cause of treatable disability. 17 Various strategies to prevent or treat vasospasm and its ischemic sequelae are under investigation, including intracisternal thrombolytic therapy, a course of 21-aminosteroids (tirilazad), intraarterial papaverine infusion, and balloon angioplasty. 16, 25 Balloon angioplasty performed shortly after symptom onset appears to improve shortterm and long-term clinical outcomes in patients suffering from symptomatic vasospasm 1, 2, 7, 14, 20, 26 Moreover, the dilation produced by balloon angioplasty appears durable, with rare vasospasm recurrence. With growing experience, enthusiasm for balloon angioplasty has increased as more neurosurgeons now use this treatment modality for symptomatic vasospasm. [4] [5] [6] [7] [8] [9] [10] [11] [12] 18, 19, 21, 23, 24 The importance of A 1 segment vasospasm as a contributor to incidences of morbidity and mortality related to vasospasm is underappreciated. The endovascular treatment of ACA vasospasm has been challenging. One disadvantage of balloon angioplasty is its limited ability to reach sharply angled vessels such as the A 1 segment. Balloon angioplasty of the A 1 segment is desirable because vasospasm in this location is common. Moreover, especially when the contralateral A 1 is hypoplastic or absent, A 1 segment vasospasm can lead to significant neurological deficits, including hemiparesis, hemihypesthesia, behavioral disturbances, transcortical motor aphasia, and mental deficits. 3 In our experience of treating more than 150 patients with balloon angioplasty for symptomatic vasospasm during the past decade, we have found that the standard 4-mm nondetachable low-pressure ITC silicone balloon can be used to dilate the A 1 segment in less than 10% of patients. The Stealth balloon microcatheter/steerable hydrophilic microguidewire technique, however, has considerably improved our ability to access and perform balloon angioplasty on vasospastic A 1 segments.
The Stealth is stiffer than the standard ITC balloon and is, therefore, more difficult to advance through the numerous genua of the ICA. Moreover, because it is a higher-pressure balloon, the use of the Stealth carries a higher risk of vessel rupture. However, our technique modification of inflating the Stealth over a hydrophilic microguidewire addresses both of these disadvantages. In contrast to the occlusive wire supplied with the Stealth, the hydrophilic microguidewire is nonocclusive because it has no ball to close the valve. Therefore, inflations are "leaky," thereby limiting the high pressure applied by the balloon to the vessel, which probably decreases the risk of vessel rupture. Moreover, because the microguidewires are steerable and hydrophilic, they can be advanced quite distally into the ACA. Advancing the Stealth over a hydrophilic microguidewire improves balloon navigation across a stenotic A 1 segment. The distally positioned microguidewire also provides support for the balloon across the acute bend of the A 1 segment during balloon inflation. Hand-inflation pressures for the Stealth ballon are typically higher (2-3 atm) than those used for the ITC (0.5 atm). In in vitro experiments performed using this modified Stealth system, hand-inflation pressures greater than 25 atm have been achieved without balloon rupture while maintaining balloon shape and caliber. Therefore, the risk of balloon rupture by using this technique appears to be low. However, overly aggressive dilation can potentially rupture the vessel segment or cause occlusive dissection. We have observed one case of transient occlusive balloon microcatheter-induced spasm following A 1 segment angioplasty in a woman who was a long-time user of tobacco (Case 7).
The Stealth balloon microcatheter/steerable hydrophilic microguidewire system can also be used to perform balloon angioplasty in the M 2 and P 1 segments in selected patients. When planning multiple-vessel-segment balloon angioplasty by using the Stealth balloon microcatheter/ steerable hydrophilic microguidewire system, A 1 segment balloon angioplasty should be attempted first because, once the Stealth is inflated, it never completely returns to its baseline low profile. This endovascular technique can also be used to perform balloon angioplasty in cases of intracranial atherosclerotic stenoses. On the horizon are new microguidewire-directed low-pressure silicone balloon microcatheters that should be capable of reaching the A 1 segment. Theoretically, these newer angioplasty balloon catheters should be safer and more maneuverable.
Conclusions
Vasospasm of the A 1 segment is common and can lead to significant morbidity. When balloon angioplasty for symptomatic vasospasm is pursued, all stenotic proximal vessel segments should be mechanically dilated, including narrowed A 1 segments, if technically achievable. We have found that the low-profile high-pressure Stealth balloon microcatheter/steerable hydrophilic microguidewire overthe-wire technique improves access to and balloon angioplasty in vasospastic A 1 segments. Use of the high-pressure Stealth balloon carries a higher risk of vessel rupture compared with the use of the standard low-pressure ITC balloon. Balloon angioplasty in a vasospastic A 1 segment should not be performed if the prevasospasm caliber of the A 1 segment is not known, hypoplastic, or atretic. 
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